Loading…
Helping Experts Accelerate Rare Treatments Act of 2021
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
43pct
1d open
vs 9,698 other HR bills in the 117th — cohort avg 63d
Helping Experts Accelerate Rare Treatments Act of 2021 This bill addresses rare diseases, including by requiring the Food and Drug Administration to ensure the inclusion of rare disease experts and staff members in various parts of the drug review process. The bill also requires certain reports to address issues related to rare diseases and drugs for treating such diseases (sometimes referred to as orphan drugs if the rarity of the disease makes it difficult for the drug to be profitable).
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (4)
2024 · first_quarter · Pharmacy
S. 1906, the Promising Pathway Act H.R.5539/S.3131, the ORPHAN Cures Act H.R. 7384, the Creating Hope Reauthorization Act H.R.4758/S.2372, the Accelerating Kids Access to Care Act H.R.6664, the Innovation in Pediatric Drugs Act H.R.1184/S.4071, the Helping Experts Accelerate Rare Treatments Act
Referred to the Subcommittee on Health.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: Not reported · Firm income: $130,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Health Issues
HEART Act HR 1184 and S 4071
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Health Issues
HEART Act HR1184 and S4071 Access to Rare Indications Act HR7567
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Health Issues
HEART Act HR1184 and S4071 Access to Rare Indications Act HR7567
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Health Issues
HEART Act HR 1184 and S 4071
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Health Issues
H.R. 1184, Helping Experts Accelerate Rare Treatments Act of 2021 S. 4071, the Helping Experts Accelerate Rare Treatments Act of 2022
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
2022 · second_quarter · Pharmacy
H.R. 1184 - Helping Experts Accelerate Rare Treatments Act of 2021 S. 4348 - FDASLA Act of 2022 H.R. 7667 - Food and Drug Amendments of 2022
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Pharmacy
H.R. 1184 - Helping Experts Accelerate Rare Treatments Act of 2021 S. 4348 - FDASLA Act of 2022 H.R. 7667 - Food and Drug Amendments of 2022
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Pharmacy
S. 4348, the FDASLA Act of 2022 H.R. 7667, the Food and Drug Amendments of 2022 S. 4071, the Helping Experts Accelerate Rare Treatments (HEART) Act H.R. 1184, the Helping Experts Accelerate Rare Treatments (HEART) Act S. 670/H.R. 1730, the Speeding Therapy Access Today (STAT) Act H.R. 6000, the Cures 2.0 Act S. 373/H.R. 4472, the Better Empowerment Now to Enhance Framework and Improve Treatments (BENEFIT) Act
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Health Issues
HEART Act HR 1184 and S 4071
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Health Issues
HEART Act HR1184 and S4071 Access to Rare Indications Act HR7567
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Health Issues
HEART Act HR1184 and S4071
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Health Issues
H.R.5376 - Build Back Better Act H.R.2623 - Camerons Law H.R.6160 - Access to Rare Indications Act of 2021 H.R.1184 - Helping Experts Accelerate Rare Treatments Act of 2021 2416- New Opportunities for Value that Extend Lives Act of 2021 S.350- Newborn Screening Saves Lives Reauthorization Act of 2021 H.R.6963 - Accelerated Approval Integrity Act of 2022 H.R.6996 - Accelerating Access for Patients Act of 2022
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Health Issues
HEART Act HR 1184
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Health Issues
H.R. 1184, the Helping Experts Accelerate Rare Treatments Act of 2021 and issues related to access to treatments for rare diseases
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Health Issues
HEART Act HR 1184
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · third_quarter · Health Issues
H.R. 1184, the Helping Experts Accelerate Rare Treatments Act of 2021 and issues related to access to treatments for rare diseases
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · second_quarter · Pharmacy
HR 1184 The Heart Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · second_quarter · Health Issues
HR 482: NEWBORN SCREENING SAVES LIVES REAUTHORIZATION ACT OF 2021; ALL PROVISIONS OF THE BILL HR 1184: HELPING EXPERTS ACCELERATE RARE TREATMENTS (HEART) ACT OF 2021; ALL PROVISIONS OF THE BILL S 350: NEWBORN SCREENING SAVES LIVES REAUTHORIZATION ACT OF 2021; ALL PROVISIONS OF THE BILL S 373: BENEFIT ACT OF 2021; PROVISIONS RELATED TO RARE DISEASES S 2164: LOWER COSTS, MORE CURES ACT OF 2021; PROVISIONS RELATED TO VALUE BASED ARRANGEMENTS GENERAL DISCUSSIONS RELATED TO THE 21ST CENTURY CURES ACT 2.0 GENERAL DISCUSSIONS RELATED TO THE ORPHAN DRUG ACT
Client expense: $190,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · second_quarter · Health Issues
H.R. 1184, the Helping Experts Accelerate Rare Treatments Act of 2021 and issues related to access to treatments for rare diseases
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · first_quarter · Pharmacy
HR 1184 The Heart Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · first_quarter · Health Issues
HR7567 The Access to Rare Indications Act HR1184 The HEART Act
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · first_quarter · Health Issues
H.R. 1184, the Helping Experts Accelerate Rare Treatments Act of 2021 and issues related to access to treatments for rare diseases
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
| Republican |
| WV |
| Don Bacon | Republican | NE |
| Eric Swalwell | Democratic | CA |
| Michael F. Q. San Nicolas | Democratic | GU |
| Sheila Jackson Lee | Democratic | TX |
| Stephanie N. Murphy | Democratic | FL |